NCT00563524 Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis Status COMPLETED Phase PHASE1
NCT00537212 Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy Status COMPLETED Phase NA
NCT00527072 PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept Status COMPLETED Phase PHASE3
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis Status COMPLETED Phase PHASE3
NCT00504270 A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis. Status COMPLETED Phase PHASE2
NCT00482170 Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept Status COMPLETED Phase PHASE3
NCT00477191 Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis Status TERMINATED Phase NA
NCT00470392 Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis Status TERMINATED Phase NA
NCT00454584 An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00443326 AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects Status COMPLETED Phase PHASE2
NCT00437619 A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis. Status COMPLETED Phase PHASE4
NCT00437216 Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis Status COMPLETED Phase N/A
NCT00436540 A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam Status COMPLETED Phase PHASE4
NCT00427609 Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications Status TERMINATED Phase PHASE2
NCT00417820 Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis. Status COMPLETED Phase PHASE1